Literature DB >> 19500846

Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.

Ling Zhou1, Katie Luneau, Cornelia M Weyand, Valérie Biousse, Nancy J Newman, Hans E Grossniklaus.   

Abstract

OBJECTIVE: To correlate the pathologic findings of temporal artery biopsies in patients clinically defined as positive, presumed, or negative for giant cell arteritis (GCA).
DESIGN: Retrospective case series. PARTICIPANTS AND CONTROLS: Patients evaluated for GCA.
METHODS: Temporal artery biopsies examined between 1989 and 2007 were studied. Clinical information and residual tissue for immunohistochemical staining was identified in 107 patients. Clinical information was used to make a diagnosis of "positive," "presumed," or "negative" GCA. The biopsies were reviewed in a masked fashion and classified as "positive," "indeterminate," or "negative" based on published, classic pathologic diagnosis (CPD) criteria. All biopsies were immunostained for CD3 and CD68 and graded as "negative," "mildly" (+), "moderately" (++), or "markedly" (+++) positive. Clinical and pathologic results were correlated and a modified pathologic diagnosis classification (MPD) scheme was developed. The modified scheme was compared in a masked fashion with the final clinical diagnosis and positive and negative predictive values (PVs) were calculated. MAIN OUTCOME MEASURES: Pathologic diagnosis and final clinical diagnosis.
RESULTS: Using the MPD classification, there were 25%, 16%, and 61% positive, indeterminate, and negative biopsies, respectively. There was excellent correlation between the modified pathologic criteria and final clinical diagnosis (correlation coefficient 0.997; P<0.0001; kappa = 0.81). The positive PVs for CPD and MPD were 85% and 96%, respectively. The negative PVs for CPD and MPD were 64% and 61%, respectively. Positive and negative biopsies strongly correlated with clinical diagnoses of positive and negative for GCA, respectively, whereas indeterminate cases moderately correlated with presumed GCA. The diagnosis did not change from the original biopsy in 11 patients who had a second biopsy. Immunostaining for CD 68 was helpful in several indeterminate cases.
CONCLUSIONS: We recommend using the modified histologic classification of temporal artery biopsies. There are indeterminate cases that cannot be further defined using current pathologic classification criteria. A second biopsy has very limited value. Immunostaining for CD68 may be helpful in indeterminate cases, although the diagnosis in these cases is based on clinical judgment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500846      PMCID: PMC2721017          DOI: 10.1016/j.ophtha.2009.02.027

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

Review 1.  Cytokines in giant-cell arteritis.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Cleve Clin J Med       Date:  2002       Impact factor: 2.321

Review 2.  Medium- and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

3.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

Review 4.  Does this patient have temporal arteritis?

Authors:  Gerald W Smetana; Robert H Shmerling
Journal:  JAMA       Date:  2002-01-02       Impact factor: 56.272

5.  Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.

Authors:  A Brack; H L Rittner; B R Younge; C Kaltschmidt; C M Weyand; J J Goronzy
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation.

Authors:  Ji W Han; Kazunori Shimada; Wei Ma-Krupa; Tiffany L Johnson; Robert M Nerem; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

7.  Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis.

Authors:  C M Weyand; A D Wagner; J Björnsson; J J Goronzy
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 8.  Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391

Review 9.  Immunopathways in giant cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Wei Ma-Krupa; Jörg J Goronzy
Journal:  Autoimmun Rev       Date:  2004-01       Impact factor: 9.754

10.  Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis.

Authors:  Wei Ma-Krupa; Myung-Shin Jeon; Silvia Spoerl; Thomas F Tedder; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

View more
  10 in total

1.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

2.  An 80-year-old woman with left-sided headache and diplopia.

Authors:  Christian M Cabrera Kang; Naymee Velez-Ruiz; James G Greene; Hans E Grossniklaus; Beau B Bruce
Journal:  Neurohospitalist       Date:  2013-07

3.  Massive and diffuse elastosis of the temporal artery.

Authors:  Frederick A Jakobiec; Alia Rashid; Michael Yoon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-24       Impact factor: 3.117

4.  Studies on the Histopathology of Temporal Arteritis.

Authors:  Angeline L Wang; Meisha L Raven; Krishna Surapaneni; Daniel M Albert
Journal:  Ocul Oncol Pathol       Date:  2016-10-15

5.  [Clinical aspects of temporal arteritis: course variations up to fatal complications].

Authors:  A Brüggemann; K Holl-Ulrich; M Müller
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

6.  Morphological features of temporal arteritis.

Authors:  William C Roberts; Saleha Zafar; Jo Mi Ko
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

Review 7.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

8.  Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis.

Authors:  José Hernández-Rodríguez; Giuseppe Murgia; Irama Villar; Elías Campo; Sarah L Mackie; Aruna Chakrabarty; Elizabeth M A Hensor; Ann W Morgan; Carme Font; Sergio Prieto-González; Georgina Espígol-Frigolé; Josep M Grau; Maria C Cid
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  The Adequate Number of Histopathology Cross-sections of Temporal Artery Biopsy in Establishing the Diagnosis of Giant Cell Arteritis.

Authors:  Roshanak Ali-Akbar Navahi; Samira Chaibakhsh; Sayyed Amirpooya Alemzadeh; Kaveh Abri Aghdam
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

10.  Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Authors:  Sarah Louise Mackie; John C Taylor; Lubna Haroon-Rashid; Stephen Martin; Bhaskar Dasgupta; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Colin T Pease; Jennifer H Barrett; Richard Watts; Ann W Morgan
Journal:  Arthritis Res Ther       Date:  2015-07-30       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.